CAR BCMA-CD70-T cells therapy (The Fifth Medical Center Of Pla General Hospital)

N/A

Report date: 2026/03/13 20:02:36

Base Information

Drug NameCAR BCMA-CD70-T cells therapy (The Fifth Medical Center Of Pla General Hospital)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionB-cell maturation protein modulatorsCD70 antigen modulatorsT lymphocyte replacements

TargetsB-cell maturation proteinCD70 antigen

Therapy Area/IndicationsNeoplasms, Plasma Cell

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesThe Fifth Medical Center Of Pla General Hospital (Formerly 307 Hospital)

China Registration ClassN/A

Develop Information

Active CompaniesThe Fifth Medical Center Of Pla General Hospital (Formerly 307 Hospital)

Inactive CompaniesN/A

Active IndicationsNeoplasms, Plasma Cell

Inactive IndicationsN/A

Other Information

ATC CodeN/A